Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Efficacy and availability of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy].
Review of the novelties from the 31st ECTRIMS Congress, 2015, presented at the 8th Post-ECTRIMS meeting.
Catalpol induces oligodendrocyte precursor cell-mediated remyelination in vitro.
Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice.
Tracking successive Wallerian degenerations in a relapsing-remitting multiple sclerosis patient.
Pediatric multiple sclerosis: Clinical features and outcome.
Early-Onset Multiple Sclerosis in Isfahan, Iran: Report of the Demographic and Clinical Features of 221 Patients.
Autologous hematopoietic stem cell transplantation in multiple sclerosis: 20 years of experience.
Inflammatory cytokines influence measures of white matter integrity in Bipolar Disorder.
Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis.
Dopamine characteristics in different rat genotypes: the relation to absence epilepsy.
Exclusive expression of the Rab11 effector SH3TC2 in Schwann cells links integrin-α6 and myelin maintenance to Charcot-Marie-Tooth disease type 4C.
MHC and non-MHC gene regulation of disease susceptibility and disease course in experimental inflammatory peripheral neuropathy.
Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment.
Methylene blue alleviates experimental autoimmune encephalomyelitis by modulating AMPK/SIRT1 signaling pathway and Th17/Treg immune response.
Characterization of the encephalitogenic immune response in a model of multiple sclerosis.
CMTX Disorder and CamKinase.
Rehabilitation in Multiple Sclerosis: a Systematic Review of Systematic Reviews.
Enhanced glucocorticoid receptor signaling in T cells impacts thymocyte apoptosis and adaptive immune responses.
Myelin-specific T helper 17 cells promote adult hippocampal neurogenesis through indirect mechanisms.
Update on therapeutic options for multiple sclerosis.
Nerve conduction and electromyography studies.
Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits.
Fampridine-PR (prolonged released 4-aminopyridine) is not effective in patients with inflammatory demyelination of the peripheral nervous system.
Gene expression profiling in multiple sclerosis brain.
Pages
« first
‹ previous
…
728
729
730
731
732
733
734
735
736
…
next ›
last »